Sudden hearing loss and early hyperbaric oxygen therapy: A preliminary study
Undersea and Hyperbaric Medicine · 2023
DOI: 10.22462/01.00.2023.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Undersea and Hyperbaric Medicine, 2023. Verfasst von Mirko Aldè und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Sudden sensorineural hearing loss (SSNHL) is a time-sensitive urgent condition. The aim of this study was to evaluate the frequency of hearing improvement in patients with idiopathic SSNHL who only received hyperbaric oxygen (HBO2) therapy within 3 days of symptom onset, instead of conventional corticosteroid treatment.
Methods
The medical charts of patients who experienced SSNHL between January 1, 2012, and December 31, 2021, were reviewed. The present study included all adult patients who were diagnosed with idiopathic SSNHL and started HBO2 therapy within 72 hours of symptom onset. These subjects did not take corticosteroids due to contraindications or because they were concerned about possible side effects. The HBO2 therapy protocol consisted of at least 10 sessions of 85 minutes each with pure oxygen inhalation at 2.5 atmospheres absolute pressure.
Results
Overall, 49 subjects (26 males and 23 females) met the inclusion criteria, with a mean age of 47 (± 20.4) years. The mean initial hearing threshold was 69.8 dB (± 18.0). After HBO2 therapy, complete hearing recovery was observed in 35 patients (71.4%), and the mean hearing threshold improved significantly (P
Zitieren
APA
Aldè, M., Cantarella, G., Piatti, G., & Ambrosetti, U. (2023). Sudden hearing loss and early hyperbaric oxygen therapy: A preliminary study. Undersea and Hyperbaric Medicine. https://doi.org/10.22462/01.00.2023.3
Vancouver
Aldè M, Cantarella G, Piatti G, Ambrosetti U. Sudden hearing loss and early hyperbaric oxygen therapy: A preliminary study. Undersea and Hyperbaric Medicine. 2023. doi:10.22462/01.00.2023.3
BibTeX
@article{Ald2023,
author = {Aldè, Mirko and Cantarella, Giovanna and Piatti, Gioia and Ambrosetti, Umberto},
title = {Sudden hearing loss and early hyperbaric oxygen therapy: A preliminary study},
journal = {Undersea and Hyperbaric Medicine},
year = {2023},
doi = {10.22462/01.00.2023.3}
}
EUVIMED